Tag: Celgene

Latest News

Celgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Met Primary and Key Secondary Endpoints

Newsemia
SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ: CELG) today announced top-line results from the international phase 3, randomized, double-blind, placebo-controlled study, QUAZAR AML-001. The study evaluated the...
Latest News

Celgene Presents Data from a Phase 1/2 Clinical Study of Iberdomide in Combination with Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma at ASCO 2019

Newsemia
SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ: CELG) today announced the first clinical results evaluating iberdomide (CC-220) in combination with dexamethasone in patients with relapsed and refractory...
Latest News

Bristol-Myers Squibb, Celgene shareholders vote to approve $74B acquisition deal

Newsemia
BMS’s acquisition of Celgene had attracted opposition from two institutional investors. However, one of them withdrew its effort to derail the deal despite continuing to...
Latest News

Celgene, following BMS buyout, forms two immuno-oncology partnerships

Newsemia
The company said Friday morning that it would partner with two companies, Kyn Therapeutics and Obsidian Therapeutics. Source link...
Latest News

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session

Newsemia
SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$CELG–Celgene and Acceleron Announce Results of MEDALIST Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session...
Latest News

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018

Newsemia
SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$CELG–Celgene Corporation and Acceleron Pharma Announce Results of BELIEVE, Evaluating Luspatercept in Adult Patients with Beta-thalassemia at ASH 2018 Source...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World